Abstract
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
J R Kalden, D L Scott, J S Smolen, M Schattenkirchner, B Rozman, B D Williams, T K Kvien, P Jones, R B Williams, C Oed, R Rosenburg and European Leflunomide Study Group
The Journal of Rheumatology September 2001, 28 (9) 1983-1991;
J R Kalden
D L Scott
J S Smolen
M Schattenkirchner
B Rozman
B D Williams
T K Kvien
P Jones
R B Williams
C Oed
In this issue
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
J R Kalden, D L Scott, J S Smolen, M Schattenkirchner, B Rozman, B D Williams, T K Kvien, P Jones, R B Williams, C Oed, R Rosenburg, European Leflunomide Study Group
The Journal of Rheumatology Sep 2001, 28 (9) 1983-1991;
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
J R Kalden, D L Scott, J S Smolen, M Schattenkirchner, B Rozman, B D Williams, T K Kvien, P Jones, R B Williams, C Oed, R Rosenburg, European Leflunomide Study Group
The Journal of Rheumatology Sep 2001, 28 (9) 1983-1991;